The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 53.00
Ask: 56.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.66%)
Open: 54.50
High: 54.50
Low: 54.50
Prev. Close: 54.50
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jan 2015 17:39

RNS Number : 3238C
MyCelx Technologies Corporation
15 January 2015
 

Not for release, publication or distribution directly or indirectly, in whole or in part, in or into or from the United States of America, its territories and possessions, any state of the United States, and the District of Columbia (collectively, the "United States"), Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MYCELX Technologies Corporation ("MYCELX" or the "Company").

 

THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO OR FOR THE ACCOUNT OR BENEFIT OF US PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE. HEDGING TRANSACTIONS INVOLVING THE COMPANY'S COMMON SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE US SECURITIES ACT.

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX)

 

15 January 2015

 

2014 Year End Trading Update & Contract Wins

 

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces a trading update ahead of its 2014 Full Year Results, which will be announced on 20 March 2015.

 

The Company now expects to report full year revenue of $13.6 million for FY2014. This reduction in revenue results in a pre-tax loss of $5.7 million and an EBITDA of negative $4.2 million.

 

The Company had expected $1.8 million of revenue from an existing client on a stored waste water

project (lease, service and media). This contract has been delayed to coincide with operational maintenance expected in Q1 2015. An additional $450K of media revenue which was expected from a waste water project with a separate customer in December was not realized as the project was completed ahead of schedule due to lower than expected water volumes. The majority of the remaining shortfall resulted from end of year media sales forecasted from existing customers that did not occur.

 

Historically, the month of December has always been a strong one for revenue in the context of the Company's respective calendar year with clients spending surplus budgets for the year. This year we anticipated a similar trend. However, following our post year end analysis we believe that clients were reluctant to spend surplus budgets in response to the significant price declines in WTI and Brent prices in the last quarter of 2014. Such material moves in commodity prices, in conjunction with the significant sizes of certain contracts we are working on, makes forecasting extremely challenging.

 

 In reference to the three major projects that the Company has stated that it expects to execute in 2015, the Company has been awarded the contract for the short term waste water project. This is currently capped at $2.9 million. The Company is in discussions relating to the two larger projects and they remain active prospects. However, given the scale of the individual projects and the unpredictability of the timing of the project awards, the revenue forecast related to these projects has been revised downward for 2015. The Company has also received a $3.6 million contract for a lease renewal with one of its major customers in the Middle East.

 

The Company believes that given the uncertainty and extreme volatility surrounding the oil and gas industry it is not prudent to maintain its present revenue forecast for 2015. Therefore, the Company is revising its 2015 revenue to a range of $24 million to $29 million. Close attention and oversight of expenses is in place to assist EBITDA profitability at the lower end of the range.

 

Connie Mixon, CEO, commented:

 

"MYCELX will continue to provide long term value to the oil and gas industry. Cost effectively treating water associated with production and process will remain an important focus even in the difficult environment of volatile oil prices. The Company believes it should be profitable in 2015 by closely managing costs in line with revenue realized throughout the year and will continue to build its business for the future."

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

+1 888 306 6843

 

Numis Securities Limited

Corporate Finance 

Stuart Skinner

Nathaniel Janks

+44 20 7260 1000

 

Corporate Broking

James Black

Ben Stoop

+44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

+44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKPDNOBKDFDD
Date   Source Headline
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update
22nd Feb 20247:00 amRNSSaudi Arabia Business Operation Sale
21st Nov 20237:00 amRNSContract Update
16th Nov 20237:00 amRNSTrading Update
26th Sep 20233:10 pmRNSResult of Annual Meeting
20th Sep 20237:00 amRNSHalf Year Results Statement
11th Jul 20237:00 amRNSContract Award
5th Jul 20233:28 pmRNSHolding(s) in Company
3rd Jul 20232:37 pmRNSContract Award & PFAS Update
21st Jun 20237:00 amRNSMailing of AR and Notice of 2023 Annual Meeting
18th May 20237:00 amRNSFinal Results for the Year Ending 31 December 2022
12th May 20237:00 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSSuccessful leach testing of PFAS media
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
8th Mar 20237:00 amRNSPilot Testing Agreement for PFAS Remediation
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
24th Jan 20237:00 amRNSContract Secured for PFAS Remediation System
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
16th Mar 20224:09 pmRNSHolding(s) in Company
11th Mar 20221:10 pmRNSDealings by Directors
11th Mar 20227:00 amRNSProposed Placing and Subscription
11th Feb 20227:00 amRNSTrading Update
2nd Feb 202211:07 amRNSHolding(s) in Company
25th Jan 20227:00 amRNSSuccessful Trial of PFAS Remediation System
10th Jan 20227:00 amRNSAward of Green Economy Mark
23rd Nov 20212:36 pmRNSHolding(s) in Company
11th Nov 202111:51 amRNSDealings by Directors
9th Nov 20214:42 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSDirector/PDMR Shareholding
28th Oct 20214:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.